Trial record 13 of 31 for:    sinovac | China

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03274102
Recruitment Status : Recruiting
First Posted : September 6, 2017
Last Update Posted : September 8, 2017
Guangdong Provincial Center for Disease Control and Prevention
Dongguan Municipal Center for Disease Control and Prevention
Information provided by (Responsible Party):
Sinovac Biotech Co., Ltd

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2017
  Estimated Study Completion Date : February 2018